The variant is similar to the LP.8.1 version of COVID-19 that now makes up 70% of U.S. cases. But officials say the new variant seems to be more transmissible and may more easily evade antibodies from ...

Prior COVID-19 vaccination did not stop the immune system from mounting a protective response to the Delta and Omicron strains, though new mutation-specific antibody production dipped slightly, ...

A new antivenom relies on antibodies from the blood of Tim Friede, who immunized himself against snakebites by injecting increasing doses of venom into his body.

In the long battle to create an effective HIV vaccine, scientists have made a major leap forward. A new study shows that a ...

Respiratory syncytial virus (RSV) is the number one cause of hospitalization in infants, accounting for about 25% of all ...

COVID-19 testing includes molecular (PCR), antigen (rapid), and antibody (serology) tests, each serving different ...

Pharmacists play a crucial role in managing treatment with chimeric antigen receptor T-cell therapy and bispecific antibodies, focusing on patient selection and side effects, explained Eileen Peng, ...

After multiple bites from cobras, mambas and other snakes, Tim Friede's antibodies open the door to an innovative universal ...

The Food and Drug Administration (FDA) has approved Nucala (mepolizumab) for the add-on maintenance treatment of adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD ...

The FDA cleared an investigational new drug application for a phase 2 trial of GRF312 ophthalmic solution, an immunoglobulin ...

New research demonstrates how specially engineered bacteria taken orally can operate as a delivery system for vaccines and antiviral therapies.

The advent of novel cancer care therapies such as chimeric antigen receptor T-cell therapy and bispecific antibodies is ...